HA

Ping Zhou1,2, Tianyi Qiu3,4, Xiang Wang5

  • 1Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China.

PubMed
概括

新的仿真血凝素 (cHA) 构造,特别是cH1-H7,显示出强大的免疫性. 这种新型流感疫苗候选者引起了广泛的抗体反应,并提供了对致命病毒挑战的完整保护.